AKTX vs VRTX: Which Stock is Better?
Side-by-side comparison of Akari Therapeutics Plc and Vertex Pharmaceuticals Inc in 2026
AKTX
Akari Therapeutics Plc
$0.16
VRTX
Vertex Pharmaceuticals Inc
$451.59
Key Metrics Comparison
| Metric | AKTX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $16.96M | $117.47B | VRTX |
| P/E Ratio | N/A | 30.21 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze AKTX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKTX or VRTX a better investment?
Comparing AKTX and VRTX: Akari Therapeutics Plc has a market cap of $16.96M while Vertex Pharmaceuticals Inc has $117.47B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKTX and VRTX?
AKTX (Akari Therapeutics Plc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKTX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKTX or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for AKTX.
Which company is more profitable: AKTX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for AKTX.
Which is the larger company: AKTX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $117.47B compared to $16.96M for AKTX.
Should I buy AKTX or VRTX in 2026?
Both AKTX and VRTX have investment merit. AKTX trades at $0.16 while VRTX trades at $451.59. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKTX and VRTX stock?
Key differences: Market Cap ($16.96M vs $117.47B), P/E Ratio (N/A vs 30.2x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).